Weekend Reads flag a wave of misleading medical studies and spotlight Max Planck retractions
TL;DR Summary
Retraction Watch’s Weekend Reads highlights a surge in misleading medical studies, calls to rethink the timing of cancer therapies, and a closer look at Max Planck’s retractions, while noting publisher actions (expressions of concern for books), notable fraud cases, and expanding databases/tools that track retractions and related integrity issues in scientific publishing.
Topics:health#cancer-therapy-timing#publishing#retractions#retractionwatch#science#scientific-misconduct
- Weekend reads: A tsunami of misleading medical studies; retraction calls cancer therapy timing into question; a closer look at Max Planck’s retractions Retraction Watch
- ‘Too Good to Be True’: A Chinese Study on Timing Cancer Therapy Is Retracted The New York Times
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce Pharma
- Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints News
- High-profile retraction tests confidence in China-led studies BioWorld News
Reading Insights
Total Reads
1
Unique Readers
3
Time Saved
6 min
vs 6 min read
Condensed
96%
1,190 → 52 words
Want the full story? Read the original article
Read on Retraction Watch